Endocannabinoid Metabolism and Traumatic Brain Injury
Traumatic brain injury (TBI) represents a major cause of morbidity and disability and is a risk factor for developing neurodegenerative diseases, including Alzheimer’s disease (AD). However, no effective therapies are currently available for TBI-induced AD-like disease. Endocannabinoids are endogeno...
Guardado en:
Autores principales: | Dexiao Zhu, Fei Gao, Chu Chen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9d698df39bc24a438ac5670d93fe8bef |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Sistema endocanabinoide y desarrollo de esteatosis hepática
por: Valenzuela,Carina, et al.
Publicado: (2014) -
Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses
por: Kenneth B. Walsh, et al.
Publicado: (2021) -
The strengths and limits of cannabinoids and their receptors in cancer: Insights into the role of tumorigenesis-underlying mechanisms and therapeutic aspects
por: Fatemeh Hosami, et al.
Publicado: (2021) -
CORRECTION OF DISTURBED NEUROIMMUNE INTERACTIONS IN EXPERIMENTAL TRAUMATIC BRAIN INJURY BY MEANS OF RECOMBINANT INTERLEUKIN 2
por: S. N. Shanin, et al.
Publicado: (2018) -
Exo70 intracellular redistribution after repeated mild traumatic brain injury
por: Lira,Matías, et al.
Publicado: (2021)